$AMLX

$28.49▲ +2.6% YTD

1 SEC 13D/G filing tracked · Last updated Oct 6, 2026

Filing History

AMLX ▲ +2.6% - Amylyx Pharmaceuticals, Inc.

CP $28.49▲ +2.6%Oct 6, 2026 · ThinkSabio Blog

$AMLX Amylyx Pharmaceuticals to Present Topline Data from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek®…